Johnson & Johnson failed to properly warn two New Jersey men that the antibiotic Levaquin could damage their tendons, a lawyer told a state jury. Officials of New Brunswick, New Jersey-based J&J and its Ortho-McNeil-Janssen Pharmaceutical unit downplayed Levaquin’s risks in warning labels even after receiving reports from Europe about tendon ruptures, said Andy Alonso, a lawyer for Paul Gaffney and Robert Beare. The two men contend they suffered Achilles-tendon injuries after taking the antibiotic.
